JP2025515116A5 - - Google Patents
Info
- Publication number
- JP2025515116A5 JP2025515116A5 JP2024564989A JP2024564989A JP2025515116A5 JP 2025515116 A5 JP2025515116 A5 JP 2025515116A5 JP 2024564989 A JP2024564989 A JP 2024564989A JP 2024564989 A JP2024564989 A JP 2024564989A JP 2025515116 A5 JP2025515116 A5 JP 2025515116A5
- Authority
- JP
- Japan
- Prior art keywords
- treg
- foxp3
- disease
- cells
- genetically modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB202206570 | 2022-05-05 | ||
| GB2206570.0 | 2022-05-05 | ||
| PCT/GB2023/051200 WO2023214182A1 (en) | 2022-05-05 | 2023-05-05 | Method for maintaining suppressive activity of regulatory t cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515116A JP2025515116A (ja) | 2025-05-13 |
| JP2025515116A5 true JP2025515116A5 (cg-RX-API-DMAC7.html) | 2026-04-16 |
Family
ID=86387161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564989A Pending JP2025515116A (ja) | 2022-05-05 | 2023-05-05 | 制御性t細胞の抑制活性を維持するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250283039A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4519417A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025515116A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119325506A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023214182A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| US12227756B2 (en) * | 2018-04-18 | 2025-02-18 | Ucl Business Ltd | Engineered regulatory T cell |
| WO2019241549A1 (en) * | 2018-06-15 | 2019-12-19 | A2 Biotherapeutics, Inc. | Foxp3-expressing car-t regulatory cells |
| EP3980035A4 (en) * | 2019-06-07 | 2023-08-23 | The Board Of Trustees Of The Leland Stanford Junior University | GENETICALLY MODIFIED CD4+ T LYMPHOCYTES FOR USE IN TREG-BASED IMMUNOTHERAPY |
| GB201915359D0 (en) * | 2019-10-23 | 2019-12-04 | Ucl Business Ltd | Engineered regulatory t cell |
| GB202013477D0 (en) * | 2020-08-27 | 2020-10-14 | Quell Therapeutics Ltd | Nucleic acid constructs for expressing polypeptides in cells |
| IL302591A (en) * | 2020-11-09 | 2023-07-01 | Quell Therapeutics Ltd | Method for cryopreservation of transgenic regulatory T cells |
-
2023
- 2023-05-05 JP JP2024564989A patent/JP2025515116A/ja active Pending
- 2023-05-05 CN CN202380045220.3A patent/CN119325506A/zh active Pending
- 2023-05-05 WO PCT/GB2023/051200 patent/WO2023214182A1/en not_active Ceased
- 2023-05-05 EP EP23724369.6A patent/EP4519417A1/en active Pending
- 2023-05-05 US US18/859,911 patent/US20250283039A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zeng et al. | Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance | |
| Ratajczak et al. | Immunological memory cells | |
| Reutner et al. | CD27 expression discriminates porcine T helper cells with functionally distinct properties | |
| GB2587988A (en) | Method for enhancing the suppressive properties of Treg cells | |
| JP6017620B2 (ja) | 単一細胞の細胞傷害性を査定するための組成物および方法 | |
| Pedros et al. | Disrupted regulatory T cell homeostasis in inflammatory bowel diseases | |
| EP2899269B1 (en) | Method for cloning t cell receptor | |
| Gerdemann et al. | Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host | |
| KR20190037243A (ko) | 면역치료를 위한 티 세포 조성물 | |
| AU2021286255B2 (en) | Adoptive T Cell therapy 2 | |
| US7932045B2 (en) | Method of isolating and proliferating autologous antigen-specific CD8+ T cell using anti-4-1BB antibodies | |
| JP2025028931A (ja) | Ebv特異的免疫細胞 | |
| JP2019520823A5 (cg-RX-API-DMAC7.html) | ||
| CN117777271B (zh) | 一种t细胞受体(tcr)及其用途 | |
| JP2021519069A5 (cg-RX-API-DMAC7.html) | ||
| JP2021518130A5 (cg-RX-API-DMAC7.html) | ||
| Laird et al. | γδ T cells acquire effector fates in the thymus and differentiate into cytokine-producing effectors in a Listeria model of infection independently of CD28 costimulation | |
| JP2023533613A (ja) | Il-10を発現する複数ドナーcd4+t細胞及びその使用 | |
| CN117106061B (zh) | 靶向巨细胞病毒抗原的tcr和表达其的t细胞及应用 | |
| CN119978140A (zh) | 一种融合蛋白、人工抗原递呈分子及其在扩增nkt中的应用 | |
| CN117777270B (zh) | 一种t细胞受体(tcr)及其用途 | |
| CN117659164A (zh) | 识别ebv抗原的t细胞受体及其应用 | |
| EP4538366A1 (en) | Enhancing lineage stability of therapeutic regulatory t cell products | |
| EP3564365B1 (en) | Transdifferentation of b lymphoid cells into t cells | |
| Saez-Cirion et al. | Memory CD8⁺ T Cells Co-expressing TCF1 and ID2 Combine Effector and Stem-like Functions in Persistent Infections |